SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
218 hedge funds and large institutions have $540M invested in Sorrento Therapeutics, Inc. in 2020 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 79 increasing their positions, 43 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
218
Holders Change
+9
Holders Change %
+4.31%
% of All Funds
3.87%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
53
Increased
79
Reduced
43
Closed
42
Calls
$90.3M
Puts
$47.9M
Net Calls
+$42.4M
Net Calls Change
-$53.9M
Top Buyers
| 1 |
BlackRock
New York
|
+$17.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.24M |
| 3 |
State Street
Boston,
Massachusetts
|
+$6.6M |
| 4 |
JPMorgan Chase & Co
New York
|
+$5.63M |
| 5 |
Goldman Sachs
New York
|
+$5.04M |
Top Sellers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$10.2M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$6.76M |
| 3 |
Morgan Stanley
New York
|
-$5.42M |
| 4 |
Millennium Management
New York
|
-$3.92M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.14M |